Pharmacological targeting of the protein synthesis mTOR/4E‐ BP 1 pathway in cancer‐associated fibroblasts abrogates pancreatic tumour chemoresistance

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Bibliographic citation: Pharmacological targeting of the protein synthesis mTOR/4E‐ BP 1 pathway in cancer‐associated fibroblasts abrogates pancreatic tumour chemoresistance ; volume:7 ; number:6 ; year:2015 ; pages:735-753 ; extent:19
EMBO molecular medicine / European Molecular Biology Organization ; 7, Heft 6 (2015), 735-753 (gesamt 19)

Creator: Duluc, Camille
Moatassim‐Billah, Siham
Chalabi‐Dchar, Mounira
Perraud, Aurélie
Samain, Rémi
Breibach, Florence
Gayral, Marion
Cordelier, Pierre
Delisle, Marie‐Bernadette
Bousquet‐Dubouch, Marie‐Pierre
Tomasini, Richard
Schmid, Herbert
Mathonnet, Muriel
Pyronnet, Stéphane
Martineau, Yvan
Bousquet, Corinne

DOI: 10.15252/emmm.201404346

URN: urn:nbn:de:101:1-2022120606310901295051

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:22 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Duluc, Camille
Moatassim‐Billah, Siham
Chalabi‐Dchar, Mounira
Perraud, Aurélie
Samain, Rémi
Breibach, Florence
Gayral, Marion
Cordelier, Pierre
Delisle, Marie‐Bernadette
Bousquet‐Dubouch, Marie‐Pierre
Tomasini, Richard
Schmid, Herbert
Mathonnet, Muriel
Pyronnet, Stéphane
Martineau, Yvan
Bousquet, Corinne

Other Objects (12)

Quercetin abrogates chemoresistance in melanoma cells by modulating ΔNp73

mTOR inhibition abrogates human mammary stem cells and early breast cancer progression markers

Blocking Oncostatin M receptor abrogates STAT3 mediated integrin signaling and overcomes chemoresistance in ovarian cancer

LAT2 regulates glutamine-dependent mTOR activation to promote glycolysis and chemoresistance in pancreatic cancer

Metformin abrogates Fusobacterium nucleatum-induced chemoresistance in colorectal cancer by inhibiting miR-361-5p/sonic hedgehog signaling-regulated stemness

Genome editing abrogates angiogenesis in vivo

Snail determines the therapeutic response to mTOR kinase inhibitors by transcriptional repression of 4E-BP1

Hepatic Sirt6 activation abrogates acute liver failure

Kapitel

4e. Livraison

Kapitel

4e. Livraison

Kapitel

5. (4ε)

Kapitel

4.e Livraison

Quercetin abrogates chemoresistance in melanoma cells by modulating ΔNp73

mTOR inhibition abrogates human mammary stem cells and early breast cancer progression markers

Blocking Oncostatin M receptor abrogates STAT3 mediated integrin signaling and overcomes chemoresistance in ovarian cancer

LAT2 regulates glutamine-dependent mTOR activation to promote glycolysis and chemoresistance in pancreatic cancer

Metformin abrogates Fusobacterium nucleatum-induced chemoresistance in colorectal cancer by inhibiting miR-361-5p/sonic hedgehog signaling-regulated stemness

Genome editing abrogates angiogenesis in vivo

Snail determines the therapeutic response to mTOR kinase inhibitors by transcriptional repression of 4E-BP1

Hepatic Sirt6 activation abrogates acute liver failure

Kapitel

4e. Livraison

Kapitel

4e. Livraison

Kapitel

5. (4ε)

Kapitel

4.e Livraison

Quercetin abrogates chemoresistance in melanoma cells by modulating ΔNp73

mTOR inhibition abrogates human mammary stem cells and early breast cancer progression markers

Blocking Oncostatin M receptor abrogates STAT3 mediated integrin signaling and overcomes chemoresistance in ovarian cancer

LAT2 regulates glutamine-dependent mTOR activation to promote glycolysis and chemoresistance in pancreatic cancer

Metformin abrogates Fusobacterium nucleatum-induced chemoresistance in colorectal cancer by inhibiting miR-361-5p/sonic hedgehog signaling-regulated stemness

Genome editing abrogates angiogenesis in vivo

Snail determines the therapeutic response to mTOR kinase inhibitors by transcriptional repression of 4E-BP1

Hepatic Sirt6 activation abrogates acute liver failure

Kapitel

4e. Livraison

Kapitel

4e. Livraison

Kapitel

5. (4ε)

Kapitel

4.e Livraison

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Pharmacological targeting of the protein synthesis mTOR/4E‐ BP 1 pathway in cancer‐associated fibroblasts abrogates pancreatic tumour chemoresistance

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Quercetin abrogates chemoresistance in melanoma cells by modulating ΔNp73

mTOR inhibition abrogates human mammary stem cells and early breast cancer progression markers

Blocking Oncostatin M receptor abrogates STAT3 mediated integrin signaling and overcomes chemoresistance in ovarian cancer

LAT2 regulates glutamine-dependent mTOR activation to promote glycolysis and chemoresistance in pancreatic cancer

Metformin abrogates Fusobacterium nucleatum-induced chemoresistance in colorectal cancer by inhibiting miR-361-5p/sonic hedgehog signaling-regulated stemness

Genome editing abrogates angiogenesis in vivo

Snail determines the therapeutic response to mTOR kinase inhibitors by transcriptional repression of 4E-BP1

Hepatic Sirt6 activation abrogates acute liver failure

4e. Livraison

4e. Livraison

5. (4ε)

4.e Livraison

Quercetin abrogates chemoresistance in melanoma cells by modulating ΔNp73

mTOR inhibition abrogates human mammary stem cells and early breast cancer progression markers

Blocking Oncostatin M receptor abrogates STAT3 mediated integrin signaling and overcomes chemoresistance in ovarian cancer

LAT2 regulates glutamine-dependent mTOR activation to promote glycolysis and chemoresistance in pancreatic cancer

Metformin abrogates Fusobacterium nucleatum-induced chemoresistance in colorectal cancer by inhibiting miR-361-5p/sonic hedgehog signaling-regulated stemness

Genome editing abrogates angiogenesis in vivo

Snail determines the therapeutic response to mTOR kinase inhibitors by transcriptional repression of 4E-BP1

Hepatic Sirt6 activation abrogates acute liver failure

4e. Livraison

4e. Livraison

5. (4ε)

4.e Livraison

Quercetin abrogates chemoresistance in melanoma cells by modulating ΔNp73

mTOR inhibition abrogates human mammary stem cells and early breast cancer progression markers

Blocking Oncostatin M receptor abrogates STAT3 mediated integrin signaling and overcomes chemoresistance in ovarian cancer

LAT2 regulates glutamine-dependent mTOR activation to promote glycolysis and chemoresistance in pancreatic cancer

Metformin abrogates Fusobacterium nucleatum-induced chemoresistance in colorectal cancer by inhibiting miR-361-5p/sonic hedgehog signaling-regulated stemness

Genome editing abrogates angiogenesis in vivo

Snail determines the therapeutic response to mTOR kinase inhibitors by transcriptional repression of 4E-BP1

Hepatic Sirt6 activation abrogates acute liver failure

4e. Livraison

4e. Livraison

5. (4ε)

4.e Livraison

Related objects

Reset password